Stay updated on Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial

Sign up to get notified when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.
    Difference
    1.0%
    Check dated 2025-01-12T17:13:27.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T12:26:25.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T10:36:45.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The website has added new features for data download options, while several key government health-related URLs and detailed data fields for studies have been removed.
    Difference
    14%
    Check dated 2024-11-23T04:21:09.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    New resources have been added, including links to major health and government websites such as HHS, NIH, NLM, NCBI, and USA.gov.
    Difference
    0.7%
    Check dated 2024-11-15T22:41:11.000Z thumbnail image
  9. Check
    72 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new download options for data in various formats (CSV, JSON, RIS, FHIR) and allowing users to select specific fields for download.
    Difference
    16%
    Check dated 2024-11-08T18:02:52.000Z thumbnail image

Stay in the know with updates to Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.